levetiracetam (Shanghai Anbison Lab)

N/A

Report date: 2025/01/26 19:16:37
NME

Base Information

Drug Namelevetiracetam (Shanghai Anbison Lab)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/Indications +[1N/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Anbison Lab Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active Indications +[1N/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A